癌症病史与冠状动脉旁路移植术后生存:SWEDEHEART注册研究经验
基于瑞典SWEDEHEART注册研究1997-2015年82137例首次孤立CABG患者的回顾性队列,8.3%有癌症病史且比例从3.8%升至14.8%。癌症病史与长期全因死亡(10年45.7% vs 22.9%,调整HR 1.33,95%CI 1.28-1.38)和癌症死亡(SHR 2.45,95%CI 2.28-2.63)增加相关,但心血管死亡风险未增加(SHR 0.88,95%CI 0.83-0.94)。
要点
- CABG患者中癌症病史比例从1997年3.8%升至2015年14.8%。
- 癌症病史者10年全因死亡45.7% vs 22.9%,调整HR 1.33。
- 癌症病史不增加心血管死亡风险(SHR 0.88)。
核心结论
- CABG时存在癌症病史与长期癌症死亡增加相关,但不增加心血管死亡。
- 无论有无癌症病史,CABG后心血管预后相似。
研究设计与样本
- 回顾性全国性人口队列研究,纳入瑞典1997-2015年82137例首次孤立CABG患者。
- 合并SWEDEHEART注册与4个全国强制性医疗注册的个体数据。
- 采用多因素Cox比例风险回归和竞争风险模型,调整年龄和性别。
- 中位随访9.0年(四分位距4.8-13.1)。
主要发现
- 6819例(8.3%)有癌症病史,年患病率从1997年3.8%增至2015年14.8%。
- 癌症病史患者更年长(72 vs 66岁;P < .001)且合并症更多。
- 10年全因死亡率癌症病史组45.7% vs 无癌症病史组22.9%(调整HR 1.33;95%CI 1.28-1.38,P < .001)。
- 癌症死亡风险增加(SHR 2.45;95%CI 2.28-2.63,P < .001)。
- 心血管死亡风险未增加(SHR 0.88;95%CI 0.83-0.94,P < .001)。
临床怎么用
- 评估CABG候选者时应关注癌症病史,但其主要影响长期癌症死亡而非心血管死亡。
- 有癌症病史者CABG后心血管预后与无癌症病史者相当。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To explore the currently unknown association between history of cancer at the time of coronary artery bypass grafting (CABG) and long-term survival. METHODS: All patients (n = 82,137) undergoing isolated first-time CABG in Sweden during 1997-2015 were included in this retrospective population-based cohort study. Individual patient data from the SWEDEHEART registry and 4 other mandatory nationwide health care registries were merged. Multivariable Cox proportional hazards regression and competing risk models adjusted for age and gender were used to assess associations between history of cancer, and long-term all-cause, cardiovascular and cancer mortality. Median follow-up was 9.0 years (interquartile range, 4.8-13.1). RESULTS: Altogether, 6819 (8.3%) of the patients had a history of cancer. The annual prevalence increased from 3.8% in 1997 to 14.8% in 2015. Patients with a history of cancer were older (72 vs 66 years; P < .001) and had more comorbidities. Long-term all-cause mortality was significantly greater in patients with a history of cancer (45.7% vs 22.9% at 10 years; adjusted hazard ratio, 1.33; 95% confidence interval [CI], 1.28-1.38, P < .001). According to the competing risk models, history of cancer was associated with an increased risk for cancer death (subdistribution hazard ratio, 2.45; 95% CI, 2.28-2.63, P < .001) but not cardiovascular death (subdistribution hazard ratio, 0.88; 95% CI, 0.83-0.94, P < .001). CONCLUSIONS: The proportion of patients undergoing CABG with a history of cancer has increased over time. History of cancer at the time of surgery is associated with increased cancer deaths over time but not cardiovascular deaths. The same cardiovascular prognosis after CABG can be expected regardless of cancer history.
引用
- Mennander AA, Nielsen SJ, Huhtala H, et al. History of cancer and survival after coronary artery bypass grafting: Experiences from the SWEDEHEART registry. J Thorac Cardiovasc Surg. 2020. PMID: 33069428. doi:10.1016/j.jtcvs.2020.09.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。